Chronic kidney disease: cardiovascular risk and cardiorenal therapy

Stages CKD by eGFR and albuminuria on the KDIGO heat map and assigns the 2026 ESC CVD–CKD risk category (moderate, high or very high). Recommends a statin-based regimen whatever the LDL-C, with the ESC/EAS LDL-C goals and the dialysis exceptions. Sets out RAS inhibition plus SGLT2 inhibitors, finerenone and semaglutide, and MRA choice in heart failure by LVEF, along with the 120–129 mmHg SBP target and the ESC 2026 advice on ACS, DAPT, DOACs and contrast. Flags the drug-dosing and contrast precautions that matter in cardiology. ESC, ACC/AHA and KDIGO recommendations are shown together.

Upload a report, lab sheet or echo picture to fill this calculator automatically.

Kidney function

Use the eGFR calculator in Basic calculations if needed

eGFR

mL/min/1.73m²

UACR

mg/g

mg/mmol × 8.84 = mg/gAge

years

Potassium

mmol/L

Systolic BP

mmHg

Comorbidities and therapy

CKD · KDIGO stage · ESC 2026

Enter the eGFR (and UACR if available).

References